Assessing the Cost-Utility of Universal Hepatitis B Vaccination Among Adults.

Eric William HallMark K WengAaron M HarrisSarah SchillieNoele P NelsonIsmael R Ortega-SanchezElizabeth RosenthalPatrick S SullivanBen LopmanJeb S JonesHeather BradleyEli S Rosenberg

Published in: The Journal of infectious diseases (2022)

Universal adult vaccination against HBV may be an appropriate strategy for reducing HBV incidence and improving resulting health outcomes.

Keyphrases

hepatitis b virus
liver failure
risk factors